The Luminal B2 subtype of HER2-positive breast cancer, which overexpressed GATA3, BCL2, and ESR1 genes, was found to account for roughly half of all HER2-positive breast cancer subtypes (Wu et al., 2015). The gene discussed is ESR1; the disease is breast carcinoma.